Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Fei Qi, Bo Chen, Jingjing Wang, Xinyi Lin, Shunan Qi, Jianliang Yang, Shengyu Zhou, Shulian Wang, Lin Gui, Hui Fang, Peng Liu, Yongwen Song, Sheng Yang, Yexiong Li & Mei Dong. (2019) Upfront radiation is essential for high-risk early-stage extranodal NK/T-cell lymphoma, nasal type: comparison of two sequential treatment modalities combining radiotherapy and GDP (gemcitabine, dexamethasone, and cisplatin) in the modern era. Leukemia & Lymphoma 60:11, pages 2679-2688.
Read now
Read now
Ruiwan Chen, Chengtao Wang, Yu Zhou & Bixiu Wen. (2018) Prognostic implications of circulating Epstein–Barr virus DNA for extranodal natural killer/T-cell lymphoma, nasal type: a meta-analysis. Cancer Management and Research 10, pages 2183-2192.
Read now
Read now
Chang Su, Kevin A. Nguyen, Harrison X. Bai, Dhikshitha Balaji, Ya Cao, Giorgos Karakousis, Paul J. Zhang, Guiying Zhang & Rong Xiao. (2018) Comparison of chemoradiotherapy with radiotherapy alone for early-stage extranodal natural killer/T-cell lymphoma, nasal type in elderly patients. Leukemia & Lymphoma 59:6, pages 1406-1412.
Read now
Read now
Articles from other publishers (12)
Fei Qi, Yan Xie, Dedao Wang, Yue Chai, Bo Chen, Yan Sun, Weiping Liu, Shunan Qi, Yuce Wei, Hui Fang, Dan Zhao, Lin Gui, Yong Yang, Xiaoli Feng, Ning Ding, Lan Mi, Shaokun Shu, Yexiong Li, Yuqin Song, Mei Dong & Jun Zhu. (2022) Comparison analysis of first-line asparaginase- versus non-asparaginase-based regimens for early-stage extranodal NK/T-cell lymphoma. Annals of Hematology 101:9, pages 2021-2034.
Crossref
Crossref
Yunfei Hu, Mengxiang Chen, Yang Song, Xiaomei Liu, Feng Gou, Jing Zhang & Yunhong Huang. (2020) Study of L-Asparaginase, Vincristine, and Dexamethasone Combined With Intensity-modulated Radiation Therapy in Early-Stage Nasal NK/T-Cell Lymphoma. American Journal of Clinical Oncology 43:4, pages 257-262.
Crossref
Crossref
Fei Qi, Wei-Hu Wang, Xiao-Hui He, Bo Chen, Lin Gui, Hui Fang, Peng Liu, Shu-Lian Wang, Jian-Liang Yang, Yong-Wen Song, Sheng Yang, Shu-Nan Qi, Sheng-Yu Zhou, Ye-Xiong Li & Mei Dong. (2018) Phase 2 Study of First-line Intensity Modulated Radiation Therapy Followed by Gemcitabine, Dexamethasone, and Cisplatin for High-Risk, Early Stage Extranodal Nasal-Type NK/T-Cell Lymphoma: The GREEN Study. International Journal of Radiation Oncology*Biology*Physics 102:1, pages 61-70.
Crossref
Crossref
Yuhua Huang, Huilan Rao, Shumei Yan, Fang Wang, Qinian Wu, Yanfen Feng & Yujing Zhang. (2017) Serum EBV EA-IgA and VCA-IgA antibodies can be used for risk group stratification and prognostic prediction in extranodal NK/T cell lymphoma: 24-year experience at a single institution. Annals of Hematology 96:8, pages 1331-1342.
Crossref
Crossref
Run-Ye Wu, Kang Liu, Wei-Hu Wang, Jing Jin, Yong-Wen Song, Shu-Lian Wang, Yue-Ping Liu, Hua Ren, Hui Fang, Qing-Feng Liu, Yong Yang, Bo Chen, Shu-Nan Qi, Ning-Ning Lu, Yu Tang, Yuan Tang, Ning Li, Han Ouyang & Ye-Xiong Li. (2017) Patterns of Primary Tumor Invasion and Regional Lymph Node Spread Based on Magnetic Resonance Imaging in Early-Stage Nasal NK/T-cell Lymphoma: Implications for Clinical Target Volume Definition and Prognostic Significance. International Journal of Radiation Oncology*Biology*Physics 97:1, pages 50-59.
Crossref
Crossref
Yexiong Li. 2017. Radiation Therapy in Hematologic Malignancies. Radiation Therapy in Hematologic Malignancies
157
180
.
A. Boros, J.-M. Michot, K. Hoang-Xuan & R. Mazeron. (2016) Place de la radiothérapie dans la prise en charge des lymphomes NK/T de type nasal et primitifs cérébraux. Cancer/Radiothérapie 20:6-7, pages 535-542.
Crossref
Crossref
Neha Mehta–Shah & Steven Horwitz. (2015) Zebras and hen's teeth: recognition and management of rare T and NK lymphomas. Hematology 2015:1, pages 545-549.
Crossref
Crossref
Liang Wang, Hua Wang, Jing-hua Wang, Zhong-jun Xia, Yue Lu, Hui-qiang Huang, Wen-qi Jiang & Yu-jing Zhang. (2015) Post-treatment plasma EBV-DNA positivity predicts early relapse and poor prognosis for patients with extranodal NK/T cell lymphoma in the era of asparaginase. Oncotarget 6:30, pages 30317-30326.
Crossref
Crossref
Liang Wang, Zhao Wang, Zhong-jun Xia, Yue Lu, Hui-qiang Huang & Yu-jing Zhang. (2015) CD56-negative extranodal NK/T cell lymphoma should be regarded as a distinct subtype with poor prognosis. Tumor Biology 36:10, pages 7717-7723.
Crossref
Crossref
Ranjit Kumar Chaudhary, Vijaya Raj Bhatt & Julie M. Vose. (2015) Management of Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type. Clinical Lymphoma Myeloma and Leukemia 15:5, pages 245-252.
Crossref
Crossref
Tianxia Deng, Cheng Zhang, Xi Zhang, Sha Wu, Yaqi Xu, Shanshan Liu & Xinghua Chen. (2014) Treatment Outcome of Radiotherapy Alone versus Radiochemotherapy in IE/IIE Extranodal Nasal-Type Natural Killer/T Cell Lymphoma: A Meta-Analysis. PLoS ONE 9:9, pages e106577.
Crossref
Crossref